Macrophage migration inhibitory factor (MIF) is a critical mediator of the innate immune response to Mycobacterium tuberculosis
暂无分享,去创建一个
G. Kaplan | L. Leng | R. Bucala | R. Das | J. David | C. Murchison | W. Burman | S. Jacob | W. Scheld | B. Kim | J. MacMicking | C. Moore | S. Subbian | Shevin T. Jacob | Jie Yao | Mi-Sun Koo | R. Levy | Rebecca J. Levy
[1] M. Newport,et al. Genetic variants of MARCO are associated with susceptibility to pulmonary tuberculosis in a Gambian population , 2013, BMC Medical Genetics.
[2] S. Ehlers,et al. Mincle is not essential for controlling Mycobacterium tuberculosis infection. , 2013, Immunobiology.
[3] T. Calandra,et al. Macrophage migration inhibitory factor deficiency is associated with impaired killing of gram-negative bacteria by macrophages and increased susceptibility to Klebsiella pneumoniae sepsis. , 2012, The Journal of infectious diseases.
[4] Ming Chen,et al. Association of tuberculosis and polymorphisms in the promoter region of macrophage migration inhibitory factor (MIF) in a Southwestern China Han population. , 2012, Cytokine.
[5] S. Chow,et al. Bacteremic disseminated tuberculosis in sub-saharan Africa: a prospective cohort study. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] J. Baeten,et al. The impact of early monitored management on survival in hospitalized adult Ugandan patients with severe sepsis: A prospective intervention study* , 2012, Critical care medicine.
[7] John P. Ray,et al. Host Genotype-Specific Therapies Can Optimize the Inflammatory Response to Mycobacterial Infections , 2012, Cell.
[8] M. Bochud,et al. A functional microsatellite of the macrophage migration inhibitory factor gene associated with meningococcal disease , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[9] H. Urlaub,et al. Syk Kinase-Coupled C-type Lectin Receptors Engage Protein Kinase C-δ to Elicit Card9 Adaptor-Mediated Innate Immunity , 2012, Immunity.
[10] Ruth R. Montgomery,et al. Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus. , 2011, Arthritis and rheumatism.
[11] M. Pirmohamed,et al. Early Deaths During Tuberculosis Treatment Are Associated With Depressed Innate Responses, Bacterial Infection, and Tuberculosis Progression , 2011, The Journal of infectious diseases.
[12] A. O’Garra,et al. The role of IL-10 in immune regulation during M. tuberculosis infection , 2011, Mucosal Immunology.
[13] F. Vannberg,et al. Human genetic susceptibility to intracellular pathogens , 2011, Immunological reviews.
[14] G. Kaplan,et al. Phosphodiesterase 4 Inhibition Reduces Innate Immunity and Improves Isoniazid Clearance of Mycobacterium tuberculosis in the Lungs of Infected Mice , 2011, PloS one.
[15] A. Sher,et al. The Syk/CARD9-coupled receptor Dectin-1 is not required for host resistance to Mycobacterium tuberculosis in mice , 2011, Microbes and infection.
[16] J. Flynn,et al. HIV-1/Mycobacterium tuberculosis Coinfection Immunology: How Does HIV-1 Exacerbate Tuberculosis? , 2011, Infection and Immunity.
[17] Dongwan D. Kang,et al. Profiling Early Lung Immune Responses in the Mouse Model of Tuberculosis , 2011, PloS one.
[18] W. L. Jorgensen,et al. Receptor agonists of macrophage migration inhibitory factor. , 2010, Bioorganic & medicinal chemistry letters.
[19] Gordon D. Brown,et al. Dectin-1: a role in antifungal defense and consequences of genetic polymorphisms in humans , 2010, Mammalian Genome.
[20] Virginia Pascual,et al. An Interferon-Inducible Neutrophil-Driven Blood Transcriptional Signature in Human Tuberculosis , 2010, Nature.
[21] J. Crump,et al. Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. , 2010, The Lancet. Infectious diseases.
[22] H. Mollenkopf,et al. The adaptor molecule CARD9 is essential for tuberculosis control , 2010, The Journal of experimental medicine.
[23] Javier Martín,et al. Analysis of MIF, FCGR2A and FCGR3A gene polymorphisms with susceptibility to pulmonary tuberculosis in Moroccan population. , 2010, Journal of genetics and genomics = Yi chuan xue bao.
[24] M. Möller,et al. Current findings, challenges and novel approaches in human genetic susceptibility to tuberculosis. , 2010, Tuberculosis.
[25] E. de Wit,et al. Past, present and future directions in human genetic susceptibility to tuberculosis. , 2010, FEMS immunology and medical microbiology.
[26] M. Lasbury,et al. Downregulation of PU.1 Leads to Decreased Expression of Dectin-1 in Alveolar Macrophages during Pneumocystis Pneumonia , 2010, Infection and Immunity.
[27] N. Kenya-Mugisha,et al. Severe Sepsis in Two Ugandan Hospitals: a Prospective Observational Study of Management and Outcomes in a Predominantly HIV-1 Infected Population , 2009, PloS one.
[28] L. Leng,et al. MIF (macrophage migration inhibitory factor) promoter polymorphisms and susceptibility to severe malarial anemia. , 2009, The Journal of infectious diseases.
[29] L. Weissfeld,et al. The influence of macrophage migration inhibitory factor gene polymorphisms on outcome from community‐acquired pneumonia , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[30] J. Bernhagen,et al. The Golgi-Associated Protein p115 Mediates the Secretion of Macrophage Migration Inhibitory Factor1 , 2009, The Journal of Immunology.
[31] N. Gow,et al. Pattern recognition: recent insights from Dectin-1 , 2009, Current opinion in immunology.
[32] L. Leng,et al. Macrophage migration inhibitory factor (MIF) is critical for the host resistance against Toxoplasma gondii , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[33] S. Akira,et al. Containment of aerogenic Mycobacterium tuberculosis infection in mice does not require MyD88 adaptor function for TLR2, ‐4 and ‐9 , 2008, European journal of immunology.
[34] J. V. van Dissel,et al. Heredity versus environment in tuberculosis in twins: the 1950s United Kingdom Prophit Survey Simonds and Comstock revisited. , 2007, American journal of respiratory and critical care medicine.
[35] A. Sher,et al. Dectin-1 Interaction with Mycobacterium tuberculosis Leads to Enhanced IL-12p40 Production by Splenic Dendritic Cells1 , 2007, The Journal of Immunology.
[36] J. Anaya,et al. Macrophage migration inhibitory factor gene influences the risk of developing tuberculosis in northwestern Colombian population. , 2007, Tissue antigens.
[37] David L. Williams,et al. Syk‐dependent ERK activation regulates IL‐2 and IL‐10 production by DC stimulated with zymosan , 2007, European journal of immunology.
[38] F. Sweep,et al. Serum and BAL macrophage migration inhibitory factor levels in HIV infected Tanzanians with pulmonary tuberculosis or other lung diseases. , 2007, Clinical immunology.
[39] T. van der Poll,et al. Mice lacking SIGNR1 have stronger T helper 1 responses to Mycobacterium tuberculosis. , 2007, Microbes and infection.
[40] M. Yadav,et al. The beta-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria. , 2006, Blood.
[41] Zeny Z. Feng,et al. Macrophage migration inhibitory factor promoter polymorphisms and the clinical expression of scleroderma. , 2006, Arthritis and rheumatism.
[42] T. Calandra,et al. Macrophage migration inhibitory factor promotes innate immune responses by suppressing glucocorticoid‐induced expression of mitogen‐activated protein kinase phosphatase‐1 , 2005, European journal of immunology.
[43] L. Leng,et al. Role for macrophage migration inhibitory factor in asthma. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[44] D. Underhill,et al. Dectin-1 activates Syk tyrosine kinase in a dynamic subset of macrophages for reactive oxygen production. , 2005, Blood.
[45] Sung-Hwan Park,et al. Simultaneous detection of microsatellite repeats and SNPs in the macrophage migration inhibitory factor (MIF) gene by thin-film biosensor chips and application to rural field studies , 2005, Nucleic acids research.
[46] R. Bucala,et al. Macrophage Migration Inhibitory Factor Reduces the Growth of Virulent Mycobacterium tuberculosis in Human Macrophages , 2005, Infection and Immunity.
[47] S. Gordon,et al. Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. , 2005, Immunity.
[48] T. Calandra,et al. Macrophage migration inhibitory factor: a regulator of innate immunity , 2003, Nature Reviews Immunology.
[49] L. Leng,et al. MIF Signal Transduction Initiated by Binding to CD74 , 2003, The Journal of experimental medicine.
[50] Christopher Dye,et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. , 2003, Archives of internal medicine.
[51] C. Sousa. Faculty Opinions recommendation of Dectin-1 mediates the biological effects of beta-glucans. , 2003 .
[52] S. Gordon,et al. Dectin-1 Mediates the Biological Effects of β-Glucans , 2003, The Journal of experimental medicine.
[53] P. Gregersen,et al. Macrophage migration inhibitory factor, MIF alleles, and the genetics of inflammatory disorders: incorporating disease outcome into the definition of phenotype. , 2003, Arthritis and rheumatism.
[54] I. Orme,et al. In Vivo IL-10 Production Reactivates Chronic Pulmonary Tuberculosis in C57BL/6 Mice1 , 2002, The Journal of Immunology.
[55] S. Kaufmann,et al. Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimurium , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[56] R. Chaisson,et al. Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial , 2002, The Lancet.
[57] S. Abe,et al. Elevated levels of serum macrophage migration inhibitory factor in patients with pulmonary tuberculosis. , 2002, Clinical immunology.
[58] John David,et al. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: Regulatory role in the innate immune response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[59] T. Calandra,et al. MIF regulates innate immune responses through modulation of Toll-like receptor 4 , 2001, Nature.
[60] Chris D. Clark,et al. Spectrographic imaging: A bird's-eye view of the health of coral reefs , 2001, Nature.
[61] A. Satoskar,et al. Migration-Inhibitory Factor Gene-Deficient Mice Are Susceptible to Cutaneous Leishmania major Infection , 2001, Infection and Immunity.
[62] Tina Peng,et al. Sustained Mitogen-activated Protein Kinase (MAPK) and Cytoplasmic Phospholipase A2 Activation by Macrophage Migration Inhibitory Factor (MIF) , 1999, The Journal of Biological Chemistry.
[63] A. Satoskar,et al. Targeted Disruption of Migration Inhibitory Factor Gene Reveals Its Critical Role in Sepsis , 1999, The Journal of experimental medicine.
[64] H. Whittle,et al. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. , 1998, The New England journal of medicine.
[65] G. Kaplan,et al. Aerosol Infection of Mice with Mycobacteria Using a Nose-Only Exposure Device , 1997 .
[66] R. Bucala,et al. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome , 1997, Nature Medicine.
[67] R. Bucala,et al. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[68] J. Bernhagen,et al. An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction , 1996, The Journal of experimental medicine.
[69] J. Bernhagen,et al. MIF as a glucocorticoid-induced modulator of cytokine production , 1995, Nature.
[70] K. Tanaka,et al. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis , 1995, Infection and immunity.
[71] J. Bernhagen,et al. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor , 1994, The Journal of experimental medicine.
[72] W. Stead,et al. Racial differences in susceptibility to infection by Mycobacterium tuberculosis. , 1990, The New England journal of medicine.
[73] S. Vermund,et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. , 1989, The New England journal of medicine.
[74] P. Barnes,et al. Predictors of short-term prognosis in patients with pulmonary tuberculosis. , 1988, The Journal of infectious diseases.
[75] J. David. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. , 1966, Proceedings of the National Academy of Sciences of the United States of America.
[76] B. Bloom,et al. Mechanism of a Reaction in Vitro Associated with Delayed-Type Hypersensitivity , 1966, Science.
[77] K. Alagarasu,et al. Immunogenetics of HIV and HIV associated tuberculosis. , 2012, Tuberculosis.
[78] D. Bratton. Neutrophil Clearance: when the party’s over, cleanup begins , 2011 .
[79] C. Janeway,et al. Innate immune recognition. , 2002, Annual review of immunology.
[80] G. D. Brown,et al. Immune recognition. A new receptor for beta-glucans. , 2001, Nature.
[81] R. Atkins,et al. Migration inhibitory factor expression in experimentally induced endotoxemia. , 1997, The American journal of pathology.